XCellCure
Dr. Biessen currently serves as a Professor of Experimental Vascular Pathology at University of Maastricht. He is the principal Investigator on multiple studies fueling the innovative technology at XCellCure including groundbreaking studies regarding the prognostic value of Cardiac Biomarkers CCL3, CCL5, and CCL18.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
XCellCure
Patented portable detection device guiding therapeutic prevention of disease preventing the first and fatal heart attack guiding treatment.